The advances on the knowledge base of obesity and future therapeutic directions.
Vettor
R
R
Department of Medical and Surgical Sciences, University of Padua, Padua, Italy.
Pagano
C
C
Federspil
G
G
D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003503:Cyclobutanes / Q000627:therapeutic use; D004734:Energy Metabolism; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D009479:Neuropeptides / Q000819:agonists / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D000077403:Orlistat
D019440:Anti-Obesity Agents; D003503:Cyclobutanes; D007783:Lactones; D009479:Neuropeptides; D000077403:Orlistat; C058254:sibutramine